The addition of human albumin to vinorelbine solution prevents venous irritation

Onkologie

Volumn 22, Issue 5, 1999, Pages 416-418

  Weiss J ^a,b   Wellens, W ^a  

^a Krankhs Barmherzigen Bruder R   (Germany)

^b Praxis fur Onkologie und Hamatologie   (Germany)

Author keywords

Human albumin; Intravenous infusion; Local reactions; Phlebitis; Vinorelbine

Indexed keywords

HUMAN ALBUMIN; NAVELBINE;

ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHLEBITIS; TREATMENT OUTCOME;

EID: 0345422717     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026980     Document Type: Article

References (18)

1. Dorr RT, Bool KL: Antidote studies of vinorelbine-induced skin ulceration in the mouse. Cancer Chemother Pharmacol 1995;36:290-292.
2. Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Gottfried M, Ruffie P, Panizo A, Gaspard MH, Ravaioli A, Besenval M, Besson F, Martinez A, Berthaud P, Tursz T: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 1994;12:360-367.
3. Hohneker JA: A summary of vinorelbine (Navelbine) safety data from North American clinical trials. Semin Oncol 1994;21(suppl 10):42-47.
4. Cecchi R, Tuci F, Giomi A, Innocenti F: Supravenous hyperpigmentation induced by vinorelbine. Dermatology 1994;188:244.
5. Misery L, Perrot JL, Vergnon JM, Boucheron S, Emonot A, Claudy A: Nécrolyse épidermique localisée après injection intraveineuse de vinorelbine (Localized epidermal necrolysis after intravenous injection of vinorelbine). Presse Medicale 1992;21: 2153.
6. Crawford J, O'Rourke M, Schiller JH, Spiridonitis CH, Yanovich S, Ozer H, Langleben A, Hutchins L, Koletsky A, Clamon G, Burman S, White R, Hohneker J: Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small cell lung cancer. J Clin Oncol 1996;14:2774-2784.
7. Kornek GV, Haider K, Kwasny W, Hejna M, Raderer M, Meghdadi S, Burger D, Schneeweiss B, Depisch D, Scheithauer W: Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor. Br J Cancer 1996;74:1668-1673.
8. Fumoleau P, Delozier T, Extra JM, Canobbio L, Delgado FM, Hurteloup P: Vinorelbine (Navelbine) in the treatment of breast cancer: The European experience. Semin Oncol 1995;22(suppl 5):22-29.
9. Depierre A, Lemarie E, Dabouis G, Gamier G, Jacoulet P, Dalphin JC: A phase II study of Navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol 1991;14:115-119.
10. Doll DC, Ringenberg QS, Yarbro JW: Vascular toxicity associated with antineoplastic agents. J Clin Oncol 1986;4:1405-1417.
11. Rittenberg CR, Gralla RJ, Rehmeyer AT: Assessing and managing venous irritation associated with vinorelbine tartrate (Navelbine). Oncol Nurs Forum 1995;22:707-710.
12. Thürlimann B: Chemotherapy-associated phlebitis: What can we do about it? Top Support Care Oncol 1992;7:8-11.
13. Lozano M, Muro H, Triguboff E, Schmilovich A, Reale M, Gil Deza E: A randomized trial for effective prevention of Navelbine (NVB) related phlebitis. Proc Annu Meet Am Soc Clin Oncol 1995; 14:535(abstr 1766).
14. Bertelli G, Dini D, Forno GB, Gozza A, Silvestro S, Venturini M, Rosso R, Pronzato P: Hyaluronidase as an antidote to extravasation of vinca alkaloids: Clinical results. J Cancer Res Clin Oncol 1994;120: 505-506.
15. Schneider SM. Distelhorst CW: Chemotherapyinduced emergencies. Semin Oncol 1989;16:572-578.
16. Bertelli G: Prevention and management of extra-vasation of cytotoxic drugs. Drug Safety 1995;12: 245-255.
17. Schütz H. Lanyi F: Estramustin i.v. Optimale Applikationsweise zur Verhütung von Venenwandschäden. Krankenhauspharmazie 1988;9:102-103.
18. Urien S. Bree F, Breillout F, Bastian G, Krikorian A, Tillement JP: Vinorelbine high-affinity binding to human platelets and lymphocytes: Distribution in human blood. Cancer Chemother Pharmacol 1993;32:231-234.